Haemonetics (NYSE:HAE) Given New $108.00 Price Target at Needham & Company LLC
Haemonetics (NYSE:HAE – Free Report) had its price target reduced by Needham & Company LLC from $112.00 to $108.00 in a research note issued to investors on Friday,Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock. A number of other brokerages also recently commented on HAE. Bank of America downgraded […]
Haemonetics (NYSE:HAE – Free Report) had its price target reduced by Needham & Company LLC from $112.00 to $108.00 in a research note issued to investors on Friday,Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock. A number of other brokerages also recently commented on HAE. Bank of America downgraded […]
